Skip to main content
. 2017 Oct 23;57(3):315–333. doi: 10.1007/s40262-017-0608-3

Fig. 3.

Fig. 3

a Plasma concentrations of ALZ-801 (prodrug) and tramiprosate (active drug) over time after single ascending oral administration of ALZ-801 loose-filled capsules at 100, 172, and 300 mg/kg in healthy volunteers (mean + SD, n = 11–16; Study 1 in Table 1). b Tramiprosate exposure (C max and AUCt) versus dose relationship indicates dose linearity. C max maximum concentration, AUC t area under the concentration–time curve from time zero to time t, SD standard deviation